Tetratide Labs: Equine and Small Animal Peptide Studies Hub
Tetratide Labs curates peer-reviewed studies on equine and small animal peptide systems for informational purposes; this repository provides scientific data without offering clinical treatment advice.
The Tetratide Labs Hub curates peer-reviewed peptide research and related scientific resources involving equine, small-animal and comparative models. This repository is provided for educational and informational purposes and does not offer clinical treatment, veterinary or dosing advice.
NEW SCIENTIFIC RESOURCE
Thymosin β4 & TB-500 Scientific Handbook
Explore the molecular biology, signalling pathways, tissue-repair research and published evidence surrounding thymosin β4 and TB-500. This 12-page educational handbook examines research relating to humans, equines, dogs and cats, together with current evidence, research limitations and competitive-sport considerations.
PDF • 12 pages • Educational scientific resource
Equine Safety Study: Peptides in Competition
This preliminary observational study assessed the short-term tolerability of injectable BPC-157 and TB-500 in 11 adult horses during controlled rehabilitation. All subjects completed the 40-day trial without adverse events, injection-site reactions, or behavioral changes. Physical examinations and blood parameters remained largely stable throughout.
PDF • 8 pages • Technical scientific resource
Disclosure: This study is for informational purposes for laboratory researchers and does not constitute veterinary medical advice.
Equine Research Highlights
Analytical and Bioanalytical Chemistry
Development of an LC/MS method for the detection of TB-500 (N-acetylated LKKTETQ) and its metabolites in equine plasma and urine
TB-500 contains the synthetic peptide LKKTETQ derived from thymosin β4 and is claimed to support wound healing and tissue repair. This study developed a sensitive LC/MS method to detect TB-500 and its metabolites in equine urine and plasma to control its misuse in equine sports.
EQUINE VETERINARY JOURNAL • 2002
Oral L-Carnitine Combined with Training Promotes Changes in Skeletal Muscle
This controlled equine study investigated whether L-carnitine supplementation influenced skeletal-muscle adaptation during training and detraining in seven two-year-old Standardbred horses. Four horses received L-carnitine while three served as controls, and all horses completed a structured treadmill-training programme. The researchers reported changes involving muscle carnitine concentrations, type-IIA muscle fibres, capillary-to-fibre measurements and glycogen-related muscle characteristics in the supplemented horses. The small sample size and combination of supplementation with exercise mean the results should not be presented as proof of improved racing performance or as general veterinary guidance.
SCIENTIFIC REPORTS • 2024
Adiposity in Mares Induces Insulin Dysregulation and Mitochondrial Dysfunction Which Can Be Mitigated by Nutritional Intervention
This study examined obesity, metabolic health and skeletal-muscle mitochondrial function in 19 older mares. Following the initial comparisons, seven obese mares received L-carnitine alone for six weeks. The researchers reported improved lipid-metabolism measurements, greater muscle oxidative capacity and reduced reactive oxygen species following L-carnitine supplementation. Insulin signalling did not significantly change during the L-carnitine phase. Because this phase involved only seven mares without a concurrent untreated control group, the findings should be presented as early equine metabolic research rather than proof of a clinical treatment or performance benefit.
Small Animal Research Highlights
The following summaries detail significant peer-reviewed papers involving small animal (canine and feline) models. These highlights explore pharmacological pathways, regenerative healing and metabolic studies relevant to veterinary peptide research.
Canine Research Highlights
AMERICAN JOURNAL OF VETERINARY RESEARCH • 1996
Effect of Locally Injected Medications on Healing of Pad Wounds in Dogs
This controlled experimental study examined full-thickness pad wounds in 12 mature English Pointers. Wounds received a tripeptide-copper complex containing glycyl-L-histidyl-L-lysine, commonly associated with GHK-Cu research, or a control treatment. Treated wounds showed increased type-I collagen during the healing period, with significantly greater type-I collagen reported in the tripeptide-copper group at day 14.
FRONTIERS IN PHARMACOLOGY • 2022
Pharmacokinetics, Distribution, Metabolism, and Excretion of Body-Protective Compound 157 in Rats and Dogs
This preclinical study investigated the absorption, circulation, metabolism and elimination of BPC-157 in laboratory rats and beagle dogs. The canine component provided species-specific pharmacokinetic and metabolite data following controlled administration. This was a compound-disposition study and should not be presented as evidence of clinical effectiveness or veterinary treatment outcomes.
REGULATORY TOXICOLOGY AND PHARMACOLOGY • 2020
Preclinical Safety Evaluation of Body Protective Compound-157, a Potential Drug for Treating Various Wounds
This preclinical toxicology study evaluated BPC-157 in mice, rats, rabbits and dogs. The researchers examined several areas of safety, including acute and repeated exposure, genetic toxicity and embryo-fetal development. The authors reported that BPC-157 was well tolerated and did not cause serious toxicity under the experimental conditions tested, including the canine component. This was a preclinical safety study and did not investigate clinical effectiveness or establish an approved veterinary treatment.
JOURNAL OF NUTRITIONAL SCIENCE • 2017
Utilisation of Supplemented L-Carnitine for Fuel Efficiency, as an Antioxidant, and for Muscle Recovery in Labrador Retrievers
Two controlled experiments examined L-carnitine supplementation in exercised Labrador Retrievers. Researchers measured activity, body composition and post-exercise biomarkers. The supplemented groups showed differences in activity intensity, lean-tissue measurements and markers associated with muscle stress and oxidative capacity. The findings relate specifically to the diets, exercise programmes and Labrador populations used in the study.
Feline Research Highlights
SCIENTIFIC REPORTS • 2024
Exogenous Oxytocin Increases Gaze to Humans in Male Cats
This controlled behavioural study investigated whether exogenous oxytocin influenced domestic cats’ social responses towards people. Male cats displayed increased gaze towards humans following oxytocin administration compared with the control condition. The findings contribute to research examining oxytocin signalling and human–cat social interaction, but they should not be interpreted as general veterinary treatment guidance.
JOURNAL OF VETERINARY INTERNAL MEDICINE • 2000
The Clinical and Metabolic Effects of Rapid Weight Loss in Obese Pet Cats and the Influence of Supplemental Oral L-Carnitine
This study evaluated privately owned obese cats participating in a controlled weight-reduction programme and examined the influence of supplemental L-carnitine. Cats receiving L-carnitine lost weight at a significantly faster rate in the reported study. The researchers also monitored clinical measurements, plasma metabolites and carnitine-related markers during the programme.
AMERICAN JOURNAL OF VETERINARY RESEARCH • 2012
Influence of Dietary Supplementation with L-Carnitine on Metabolic Rate, Fatty-Acid Oxidation, Body Condition, and Weight Loss in Overweight Cats
Thirty-two adult neutered cats were assigned to diets containing different concentrations of L-carnitine during a controlled weight-reduction study. Supplemented cats demonstrated changes in metabolic measurements associated with fatty-acid oxidation and resting energy expenditure relative to lean body mass. Overall weight loss was primarily driven by dietary restriction, and the study should not be presented as evidence that L-carnitine alone produces weight loss.
Scientific Disclaimer: The abstracts and studies presented here are curated from public peer-reviewed databases for educational purposes. Tetratide Labs does not endorse specific clinical outcomes and notes that research in small animal models may not translate directly to clinical feline or canine veterinary standards. These peptides remain strictly for laboratory research and are not approved for domestic or competition animal administration.